Angelica Williams

Statistics

Publications

Citations

3.4K

H-Index

Active since

1996

Affiliations

Amplyx Pharmaceuticals (United States)(Current)

Angelica Williams is an author at Amplyx Pharmaceuticals (United States) specializing in adenovirus biology, adenovirus vectors, and adenoviral vectors.

Publications per year

1996–2000

Publications

An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

James R. Bischoff, David H. Kirn, Angelica Williams et al. · Science · 1996 · 1.8K citations

Medicine, Cancer Biology, Oncology +14

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

Carla Heise, Adam Sampson-Johannes, Angelica Williams et al. · Nature Medicine · 1997 · 947 citations

Medicine, Oncology, Pharmacology +13

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

Carla Heise, Terry Hermiston, Leisa Johnson et al. · Nature Medicine · 2000 · 585 citations

Medicine, Oncology, Pharmacology +12

Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: Intratumoral spread and distribution effects

Carla Heise, Angelica Williams, Jack Olesch et al. · Cancer Gene Therapy · 1999 · 117 citations

Medicine, Cancer Biology, Oncology +14

1–4 of 4